TRX is up-regulated by fibroblast growth factor-2 in lung carcinoma

APMIS

Volumn 119, Issue 1, 2011, Pages 57-65

  Deng, Zheng Hao ^a   Cao, Hui Qiu ^a   Hu, Yong Bin ^a   Wen, Ji Fang ^a   Zhou, Jian Hua ^a  

^a Central South University   (China)

Author keywords

FGF 2; Lung cancer; Proteomics; Trx

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FIBROBLAST GROWTH FACTOR 2; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; THIOREDOXIN; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE L1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOKINES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SMALL CELL LUNG CARCINOMA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPEROXIDE DISMUTASE; THIOREDOXINS; UBIQUITIN THIOLESTERASE; UP-REGULATION;

EID: 78650144798     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02692.x     Document Type: Article

References (36)

1. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008;359:1367-80.
2. Liu M, Xin YL, Chen FM. Immunohistochemical study of transforming growth factor-alpha in human lung cancers. Tumor Biol 1992;13:294-8.
3. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, et al. Synthesis of messenger RNAs for transforming growth factors a and b and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-12.
4. Brattström D, Bergqvist M, Hesselius P, Larsson A, Wagenius G, Brodin O. Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer. Lung Cancer 2004;43:55-62.
5. Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 2005;16:179-86.
6. Dell'Era P, Coco L, Ronca R, Sennino B, Presta M. Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. Oncogene 2002;21:2433-40.
7. Vercoutter-Edouart AS, Czeszak X, Crépin M, Lemoine J, Boilly B, Le Bourhis X, et al. Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res 2001; 262:59-68.
8. Xiao DS, Wang KS, Zhou JH, Cao HQ, Deng ZH, Hu YB, et al. Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase C alpha activation and subcellular translocation of Smac in human small cell lung cancer cells. Acta Biochim Biophys Sin 2008;40:297-303.
9. Yang YX, Sun XF, Cheng AL, Zhang GY, Yi H, Sun Y, et al. Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line. J Cancer Res Clin Oncol 2009;135:181-9.
10. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC Tumours of the Lung Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004; 9-124.
11. Ohta T, Yamamoto M, Numata M, Iseki S, Tsukioka Y, Miyashita T, et al. Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas. Br J Cancer 1995;72:824-31.
12. Yiangou C, Gomm JJ, Coope RC, Law M, Luqmani YA, Shousha S, et al. Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. Br J Cancer 1997;75:28-33.
13. Dellacono FR, Spiro J, Eisma R, Kreutzer D. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg 1997;174:540-4.
14. Song S, Wientjes MG, Gan Y, Au JL. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proc Natl Acad Sci USA 2000;97:8658-63.
15. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;2:1431-7.
16. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-30.
17. Hufton SE, Moerkerk PT, Brandwijk R, De Bruïne AP, Arends JW, Hoogenboom HR. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 1999;463:77-82.
18. Folgueira MA, Carraro DM, Brentani H, Patrão DF, Barbosa EM, Netto MM, et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 2005;11:7434-43.
19. Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, Katai H. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 2009;44:685-90.
20. Reddy PS, Umesh S, Thota B, Tandon A, Pandey P, Hegde AS, et al. PBEF1/NAmPRTase/Visfatin a potential malignant astrocytoma/glioblastoma serum marker with prognostic value. Cancer Biol Ther 2008;7:663-78.
21. Bae SK, Kim SR, Kim JG, Kim JY, Koo TH, Jang HO, et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Lett 2006;580:4105-13.
22. Shi YH, Wang YX, Bingle L, Gong LH, Heng WJ, Li Y, et al. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J Pathol 2005;205:530-6.
23. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 2003;12:1945-58.
24. Kim HJ, Kim YM, Lim S, Nam YK, Jeong J, Kim HJ, et al. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 2009;28:117-27.
25. Hibi K, Westra WH, Borges M, Goodman S, Sidransky D, Jen J. PGP9.5 as a candidate tumor marker for non small-cell lung cancer. Am J Pathol 1999;155:711-5.
26. Sasaki H, Yukiue H, Moriyama S, Kobayashi Y, Nakashima Y, Kaji M, et al. Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer. Jpn J Clin Oncol 2001;31:532-5.
27. Monari M, Trinchero A, Calabrese C, Cattani O, Serrazanetti GP, Foschi J, et al. Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer. Biomarker 2006;11:574-84.
28. Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005;24:367-80.
29. Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 1997;32:229-33.
30. Kaimul AM, Nakamura H, Masutani H, Yodoi J. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med, 2007;43:861-8.
31. Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y, Nakamura H, Yodoi J, et al. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res, 2005;11:8425-30.
32. Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 2001;30:421-55.
33. Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, Gustafsson JA, Spyrou G. Human mitochondrial thioredoxin: involvement in mitochondrial membrane potential and cell death. J Biol Chem 2002;277:33249-57.
34. Kurz DJ, Hong Y, Trivier E, Huang HL, Decary S, Zang GH, et al. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:748-54.
35. Osborne SA, Hawkes HJ, Baldwin BL, Alexander KA, Svingen T, Clarke FM, et al. The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structure. Biochem J 2006;398:269-77.
36. Bloomfield KL, Osborne SA, Kennedy DD, Clarke FM, Tonissen KF. Thioredoxin-mediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter. Gene 2003;319:107-16.